Results from years of work from he great Peter Roelvink, David Suey and team. Also inclusions of the work of the great John Rossi. Over 99% knockdown of HBsAg antigen
"Our pre-clinical results demonstrate that a one-time treatment of BB-103 added on top of a daily dosing regimen of a NUC, results in a far superior suppression of HBV parameters, including a greater than 2 log knockdown of HBsAg, as compared to that NUC inhibitor alone."
Results from years of work from he great Peter Roelvink, David...
Add to My Watchlist
What is My Watchlist?